SynthesisFrontiers in oncology2022

Prognostic molecular biomarkers in chordomas: A systematic review and identification of clinically usable biomarker panels.

Franco Rubino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.